Viking Therapeutics (VKTX)
(Delayed Data from NSDQ)
$32.68 USD
+0.11 (0.34%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $32.70 +0.02 (0.06%) 7:58 PM ET
4-Sell of 5 4
D Value F Growth F Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Viking Therapeutics, Inc. has a market cap of $3.66B, which represents its share price of $32.57 multiplied by its outstanding shares number of 112.44M. As a mid-cap company, VKTX's shareholders are generally exposed to less risk than shareholders of small-cap companies but more risk than large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
VKTX 32.68 +0.11(0.34%)
Will VKTX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for VKTX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for VKTX
NVO Stock Crashes 22% After 2025 View Cut: More Downside Ahead?
VKTX Stock Down on Wider-Than-Expected Loss in Q2, Nil Sales
VKTX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Viking Therapeutics Gears Up for Q2 Earnings: Here's What to Expect
Can Wegovy & Ozempic Drive Another Strong Quarter for Novo Nordisk?
Is It Worth Investing in Viking Therapeutics (VKTX) Based on Wall Street's Bullish Views?
Other News for VKTX
Novo Nordisk's Downgraded Expectations - What The Market Is (Obviously) Missing
Benzinga Bulls And Bears: T-Mobile, LendingTree, Molina Healthcare — And Trade Deal Optimism Boosts Markets
Benzinga Bulls And Bears: T-Mobile, LendingTree, Molina Healthcare — And Trade Deal Optimism Boosts Markets
Viking Therapeutics Q2: Confidently Continuing The Recovery
Viking Therapeutics Receives Buy Rating Amid Promising Clinical Developments and Strategic Initiatives